• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AMGA Calls for Medicare Reform

Press Release
Article

AMGA's response to an RFI from CMS on regulatory relief in Medicare stresses the never-ending need to focus on patient care instead of working to meet administrative compliance requirements.

Alexandria, Virginia — A full 2 weeks before HHS and CMS announced their intent to revamp the currently oft-despied prior authorization process, the American Medical Group Association addressed the issue, along with improving the documentation process, harmonizing quality measure reporting across CMS programs, and maintaining flexibilities for telehealth services in its response to CMS' Medicare Rrgulatory Relief request for information (RFI).

The RFI asked such questions as what changes can be made to simplify Medicare reporting and documentation requirements without affecting program integrity, are there documentation or reporting requirements within the Medicare program that are overly complex or redundant, and how can Medicare better align its requirements with best practices and industry standards without imposing additional regulatory requirements?

Jerry Penso, MD, MBA | Image Credit: AMGA

Jerry Penso, MD, MBA | Image Credit: AMGA

"Medicare’s regulatory framework is due for an update, and AMGA is pleased CMS is looking to modernize the system," said Jerry Penso, MD, MBA, AMGA president and CEO.

AMGA's response stressed the never-ending need to focus on patient care instead of working to meet administrative compliance requirements, and "ensuring regulations support rather than hinder the ability of multispecialty group practices and integrated systems of care to best meet the needs of their patients and community."

Read all about this report, and to see AMGA's complete response to CMS, click here.

Related Videos
Dr Sundar Jagannath
Hamlet Gasoyan, PhD
Eric Lander, MD
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Hamlet Gasoyan, PhD
Dr Matthew Matasar
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.